Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to investigate the effect of ACE inhibitors and the
sacubitril-valsartan complex in bone marrow transplant patients by assessing cardiovascular
and endothelial parameters in order to search for a potent protective role.
Phase:
N/A
Details
Lead Sponsor:
University of Athens
Treatments:
Angiotensin-Converting Enzyme Inhibitors LCZ 696 Sacubitril and valsartan sodium hydrate drug combination Valsartan